台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    69.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    112
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-兆豐-大安 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-大安 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/260.469.5000.0069.300.42410.15%
2024/03/0100.00152.5054.80-1183-0.54%
2023/10/2400.00129.3029.50-188-1.13%
2023/07/31122.9500.0022.901821.21%
2023/03/1700.000.119.6519.95-0.153-0.19%
2022/12/2300.00216.0516.05-219-10.27%
2022/07/2600.00614.3515.05-6102-5.85%
2022/07/25613.7500.0013.756837.15%
2022/06/2400.00112.6012.75-1157-0.64%
2022/05/1800.00513.9013.90-5147-3.38%
2022/04/2200.00115.5515.65-1121-0.82%
2022/04/18516.8500.0016.955925.42%
2022/02/0900.00215.6815.70-2123-1.62%
2021/12/2000.001016.7516.60-10114-8.76%
2021/11/2900.00217.1017.00-2101-1.98%
2021/11/2500.000.115.0515.40-0.181-0.12%
2021/11/111016.35816.3516.002822.44%
2021/11/108.116.5000.0016.508.17510.78%
2021/10/29115.0000.0015.051711.40%
2021/08/0300.00116.0515.90-1371-0.27%
2021/07/13115.9500.0015.8514040.25%
2021/06/22115.8000.0015.5514740.21%
2021/06/0800.00116.7516.65-1476-0.21%
2021/05/1700.00118.7519.60-1506-0.20%
2021/04/1900.00518.0018.10-5335-1.49%
2021/04/1600.00118.2018.20-1332-0.30%
2021/04/13619.7000.0018.2063221.86%
2021/03/0200.00817.7917.40-8256-3.12%
2021/02/26818.0600.0018.1582303.48%
2021/02/2300.00118.2017.45-1193-0.52%
2021/02/22117.6000.0017.6011760.57%
2021/01/2100.001015.3615.20-10207-4.81%
2021/01/0400.00417.0517.05-4350-1.14%
2020/11/17119.1000.0019.2013920.25%
2020/10/22121.0000.0021.2015610.18%
2020/10/2100.00121.5021.75-1544-0.18%
2020/10/20119.8000.0019.8015460.18%
2020/08/11323.0300.0022.6032,3220.13%
2020/08/10123.9500.0023.7012,3120.04%
2020/08/04325.2800.0025.5032,2780.13%
2020/07/2800.003024.0723.40-302,265-1.32%
2020/07/2100.001026.5827.45-102,149-0.47%
2020/07/2000.00423.8025.00-42,109-0.19%
2020/07/16229.8500.0029.0522,0180.10%
2020/07/15231.4000.0030.8021,9830.10%
2020/07/14232.2300.0029.6021,9070.10%
2020/07/13229.5500.0031.5521,7930.11%
2020/07/0700.00122.0021.60-11,505-0.07%
2020/07/061023.15223.2023.1581,4760.54%
2020/06/1800.00124.4022.85-11,372-0.07%
2020/06/1700.001025.3525.35-101,350-0.74%
2020/06/16125.5000.0025.9011,2940.08%
2020/06/1200.00121.4022.00-11,124-0.09%
2020/06/0300.00217.1517.60-2963-0.21%
2020/05/27223.75121.6019.4519470.11%
2020/05/26121.6000.0021.6019020.11%
2020/05/25119.6000.0019.6519350.11%
2020/05/0800.00412.0811.80-4778-0.51%
2020/05/06512.8600.0012.6557610.66%
2020/05/05212.9000.0012.4027420.27%
2020/03/101012.7500.0012.75105441.84%
2020/02/2700.00114.0013.30-1359-0.28%
2020/02/25112.0500.0012.8012640.38%
2020/02/0500.00210.6510.35-2160-1.24%
2020/02/04211.3000.0010.8021561.28%
2019/10/0300.001610.5710.50-16148-10.74%
2019/10/0100.00410.7510.95-4153-2.60%
2019/09/27210.9000.0010.8021581.26%
2019/09/2500.00410.8510.90-4183-2.18%
2019/09/1121.511.6700.0011.8021.517012.59%
2019/08/14010.3500.0010.2501490.01%
2019/08/13010.3500.0010.3001490.02%
2019/07/300.111.0000.0010.800.11480.04%
2019/07/250.111.5000.0011.400.11460.09%
2019/07/2400.00411.6511.65-4144-2.78%
2019/07/230.311.75211.8511.75-1.7144-1.17%
2019/07/19411.7400.0011.7541342.97%
2019/07/18212.2000.0012.2021231.62%
2019/07/0900.00310.2510.25-397-3.07%
2019/07/0500.00811.1211.05-897-8.16%
2019/07/04311.3200.0011.453943.18%
2019/07/03311.1000.0011.353903.31%
2019/07/02510.8500.0010.855776.45%
2019/05/0300.00111.7011.65-1112-0.89%
2019/03/15113.0000.0012.9011450.69%
2019/01/1500.001013.1513.40-10101-9.86%
2019/01/141013.9500.0014.00109410.62%
2018/12/1700.00311.3511.25-363-4.75%
2018/12/12311.2000.0011.353614.88%
2018/04/1600.00121.3521.35-1329-0.30%
2018/04/13123.8000.0023.7013020.33%
2018/04/1100.00223.3022.90-2232-0.86%
2018/04/10222.8500.0022.8521891.05%
2018/02/2600.00519.2219.50-5207-2.41%
2018/02/23519.0000.0019.3052032.46%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音